Brian Nichols is the co-founder of Angel Squad, a community where you’ll learn how to angel invest and get a chance to invest as little as $1k into Hustle Fund's top performing early-stage startups

Key takeaways

• Anthropic raised a $73 billion Series H-1 in May 2026 at a $965 billion valuation and $589 per share, led by Sequoia, Greenoaks, Dragoneer, and Altimeter, up 171% from a round that closed just three months earlier.
• Secondary units trade near $625.26, about 6% above the last round price, up nearly 890% over twelve months, with the real-time market cap crossing $1 trillion.
• Run-rate revenue was $14 billion as of February 2026 per the company, growing more than 10x annually for three straight years. That is one of the steepest curves ever recorded.
• Even so, the secondary values the company at roughly 70x that run rate, and Anthropic is still burning heavily on compute.
• Anthropic does not allow direct stock transfers, so access is indirect only, through SPVs or forward purchase contracts, both of which carry real risks.

Let's just start with the number that breaks your brain a little. Anthropic's secondary units are up almost 890% in a year, and the company is now worth more than a trillion dollars on the secondary market. Its run-rate revenue went from about $3 billion in mid-2025 to $14 billion by February 2026. That is not a typo, and it is not hype for its own sake. Claude and Claude Code are being bought by real enterprises at a scale that almost nothing in software history matches.

So the growth is real. The only question worth your time is whether the price makes sense, and that is where you have to actually sit down and do arithmetic instead of feeling the FOMO. Let's do it.

What the Numbers Actually Say

Entry price versus the last round. The Series H-1 closed in May 2026 at $589.01 per share and a $965 billion valuation. Notice's secondary consensus sits near $625.26, roughly 6% above that. On its own, a 6% premium is modest. The unnerving part is the context: that round is seven days old in this report, and it was itself a 171% step up from the $380 billion round that closed in February. Anthropic has run through Series E, F, G, and H in about fifteen months, each roughly two to three times the last. You would be paying a premium to a valuation that already tripled twice this year.

Trailing multiple. Here is where the discipline comes in. The market cap is about $1.03 trillion. Anthropic's most recent company-confirmed figure is a $14 billion run rate as of February 2026. That works out to roughly 70x. The data report shows a lower-looking multiple around 42x, but that uses a projected run rate closer to $24 billion, which is ahead of anything the company has confirmed. Anchor to the real number and you are paying about 70 times run-rate revenue for a business that did not exist five years ago. This is exactly the moment our note on why multiples decide your outcome earns its keep, because at 70x, the growth has to keep being historic just to justify the entry.

Forward multiple. The company has guided toward as much as $18 billion in revenue for 2026, with a best case run rate near $26 billion by year end, then $55 billion projected for 2027 and $70 billion for 2028. If you credit the $26 billion figure, the multiple drops to around 40x. If you credit the 2028 number and Anthropic actually gets there, today's price is roughly 15x on that year. Those forward numbers are the entire bull case. They are also projections about a market that reprices itself every quarter, so treat them as a scenario, not a promise.

Peer comparison. Set Anthropic's roughly 70x run rate next to the other names accredited investors are looking at right now. Databricks trades around 29x on the secondary. Stripe, a profitable business, trades near 22x. Public AI and software companies trade far below all of them. So Anthropic is not just expensive in the abstract, it is expensive relative to its own fast-growing private peers, and you are paying that premium for the fastest grower with the largest cash burn. That can be the right trade. It is not a cheap one.

Revenue trajectory and profitability. The trajectory is the best argument in the whole analysis: roughly $1 billion run rate at the start of 2025, over $5 billion by August, over $9 billion by year end, and $14 billion by February 2026. Claude Code alone crossed $2.5 billion. Revenue per employee is above $2.8 million, which is absurd in the best way. The offset is cash. Anthropic burns enormous amounts on compute and talent, and it does not project positive cash flow until around 2028. So you are buying blistering top-line growth funded by heavy losses, on the belief that scale eventually flips the model to profit. Underwrite the burn, not just the growth.

The Demand Side Is Red Hot

Notice reports demand outstripping the supply of available shares by 2.9 to 1. Nearly three buyers for every seller. That imbalance is a big part of why the secondary trades above a week-old round, and it tells you the enthusiasm is not slowing.

This is the exact dynamic our very own Hustle Fund GP, Elizabeth Yin, points to when she talks about pricing. As she puts it, valuations come down to supply and demand: the supply of a tranche of shares against the demand from investors chasing it. A 2.9-to-1 ratio is that dynamic running as hot as it gets. It is a real signal that the smartest capital in the world wants in. It is also the thing that reverses fastest, and when a name like this is priced for perfection, a shift in sentiment does not need much to sting.

The Hype Question, Answered Honestly

AI is the most hyped sector on the planet, so the fair test is whether Anthropic is genuinely different or just surfing the wave. Elizabeth's long-standing bar for any hyped market is whether a company is "10x different and 10x better" than the alternatives. Anthropic has a legitimate claim. Frontier model performance, a genuine enterprise sales motion, and Claude Code as a category-defining product are not costume, they are a moat. That is what separates it from the unicorns built on hype rather than data.

The bear case is not that the product is weak. It is that a handful of extraordinarily well-funded competitors are fighting for the same frontier, compute costs are brutal, and a 70x multiple leaves zero room for a stumble. Both things are true. At this price, you are betting the moat holds and the growth stays historic, simultaneously.

How You Would Actually Buy It (And Why That Matters)

Anthropic does not allow direct stock transfers. That single fact shapes the whole trade. You cannot hold shares in your own name. Your exposure has to come through a vehicle, and the two common ones are special purpose vehicles and forward purchase contracts. If you want the mechanics of how these pool capital into one late-stage position, our SPV strategy guide lays it out. Two risks deserve real attention here, and they are amplified when a name is this hot and this contested for allocation.

Risk one: forward purchase contracts are synthetic exposure. A forward is not a share. It is a contract in which a current holder promises to deliver shares or their value to you later, usually at an exit. You are not on the cap table. You hold a promise. If the seller defaults, or Anthropic blocks the transfer, or the seller's own arrangement unwinds, you become an unsecured creditor of a counterparty rather than an owner of the company. With no IPO date in sight, that counterparty risk rides along for years. Confirm exactly who stands behind any forward before you touch it.

Risk two: second and third-layer SPVs stack fees and bury your cost basis. In a name with three buyers per seller, the vehicle offered to you is frequently not the one holding the stock. It is an SPV that bought into another SPV that holds a forward that references the shares. Every layer adds a management fee and a slice of carry, and every layer makes your real entry price harder to see. On a company already trading at 70x, a couple of extra layers can quietly push your effective multiple higher without you ever seeing the true number. Ask how many layers sit between your check and the actual shares, and what each one charges. Bring the same scrutiny you would to protective terms on any deal, and think about your eventual exit before you enter, because you may be holding this a long time.

What Has to Go Right, and What Has to Go Wrong

Bull case: revenue keeps compounding toward the $55 billion and $70 billion projections, the model flips to real cash generation by 2028, Anthropic lists at a valuation that makes a trillion dollars look early, and 70x becomes a rounding error in hindsight. Given the trajectory, not crazy.

Bear case: growth decelerates from historic to merely excellent, the multiple compresses toward its peers, your 6% premium to a week-old round evaporates, the compute burn runs longer than planned, and the indirect structure clips your upside with fees while exposing you to counterparty risk. Also not crazy, and badly underpriced by a market bidding 2.9 to 1.

The honest summary is that this is a bet on continued perfection at a price that assumes it. That is a very different thing from a bargain, even when the company is genuinely extraordinary.

The Bottom Line

Anthropic might be the most important company of this cycle, and the growth numbers are the real deal. None of that changes the arithmetic: at roughly 70x a confirmed run rate, entering about 6% above a round that is a week old, through an indirect structure that takes its cut, you are paying a historic price for a historic company. That can absolutely work. It just deserves clear eyes rather than a reflex to click "invest" because the line goes up.

This is precisely the kind of deal where a serious community pays for itself, because the difference between confirmed revenue and projected revenue, and the fee load hiding inside a stack of SPVs, is exactly what gets missed in a frenzy. That is a big part of why Angel Squad exists. It is a community of more than 2,500 investors across 50-plus countries who have collectively put over $30 million into 70-plus startups, with a strict no-a-holes policy and access to the top 1% of deal flow. Hustle Fund is an early-stage fund, but Squad members see the full spectrum, from pre-seed through pre-IPO names of this caliber, with the context to actually vet the numbers and the structure before wiring. Learn more at hustlefund.vc/squad.

Frequently Asked Questions

What is Anthropic's current valuation? Anthropic was valued at $965 billion in its May 2026 Series H-1. On the secondary market, Notice puts its real-time market cap just above $1 trillion as of early June 2026, reflecting demand above the last round price.

What is Anthropic's secondary share price? Secondary units trade near $625.26 as of early June 2026, about 6% above the $589 Series H-1 price. That figure is an algorithmic consensus from secondary activity and reference data, not a guaranteed execution price.

How much revenue does Anthropic generate? Anthropic reported a $14 billion run rate as of February 2026, up from about $1 billion at the start of 2025 and growing more than 10x annually for three years. Some data reports show a higher figure, but that is a forward projection.

Is Anthropic profitable? No. Anthropic spends enormous amounts on compute and research and is not expected to reach positive cash flow until around 2028, based on its own projections. You are buying growth funded by heavy losses.

Can I buy Anthropic stock directly? No. Anthropic does not permit direct stock transfers. Accredited investors access it indirectly through special purpose vehicles or forward purchase contracts, each carrying fees and counterparty considerations.

When will Anthropic IPO? There is no confirmed timeline. Any secondary purchase should be underwritten as a multi-year, illiquid hold at a price that already assumes years of continued hypergrowth.